Pune, Jan. 29, 2024 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Veterinary Vaccines Market is expected to clock US$ 19.12 billion by 2031 and to grow at a CAGR of 5.90% during the forecast period.
The global Veterinary Vaccines Market is experiencing robust growth, driven by the increasing awareness of animal health, the rising incidence of animal diseases, and the continuous advancements in veterinary medicine. A comprehensive analysis of the market reveals a dynamic landscape dedicated to protecting and promoting the well-being of animals through preventive vaccination.
Get a Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/veterinary-vaccines-market/7655
Veterinary Vaccines Market Scope
| Report Attribute | Details |
| Market Size Value in 2022 | US$ 11.41 billion |
| Revenue Forecast in 2031 | US$ 19.12 billion |
| CAGR | 5.90% |
| Base Year for Estimation | 2022 |
| Forecast Period | 2023 to 2031 |
| Historical Year | 2021 |
| Segments Covered | Animal type, Route Of Administration, Vaccine Type, and Region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Market Overview:
Veterinary vaccines play a crucial role in preventing and controlling infectious diseases in animals, contributing to the overall health and productivity of livestock and companion animals. The market is witnessing significant expansion as the importance of animal health gains recognition, and veterinary professionals and pet owners alike prioritize preventive healthcare measures.
Key Market Drivers:
- Rising Incidence of Animal Diseases: The increasing prevalence of infectious diseases in animals, including livestock and pets, is a primary driver for the growth of the veterinary vaccines market. Vaccination is a key preventive strategy to control the spread of diseases and protect animal populations.
- Growing Awareness of Zoonotic Diseases: The awareness of zoonotic diseases, which can be transmitted from animals to humans, is driving the demand for effective vaccination in animals. Preventing diseases in animals not only safeguards their health but also contributes to public health by reducing the risk of zoonotic transmission.
- Advancements in Vaccine Development: Ongoing research and technological advancements in vaccine development are leading to the creation of more effective and targeted veterinary vaccines. Novel approaches, such as recombinant DNA technology and subunit vaccines, are enhancing the efficacy and safety of vaccines for diverse animal species.
Competitive Landscape:
The global Veterinary Vaccines market features a competitive landscape with key players contributing to research and development efforts and market growth. The report profiles major companies, offering insights into their product portfolios, market share, distribution networks, and recent innovations.
Challenges and Opportunities:
While the Veterinary Vaccines market presents significant opportunities, challenges such as the cost of vaccine development, regulatory considerations, and the need for vaccination awareness among animal owners exist. However, the potential for expanding vaccine coverage, increasing government initiatives, and the integration of digital technologies in veterinary healthcare offer avenues for market expansion.
Table of Content
- INTRODUCTION
-
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2021
- Base Year – 2022
- Forecast Years – 2023 to 2031
- Currency Used in the Report
- RESEARCH METHODOLOGY
-
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
-
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2022)
- Regulatory Landscape
- Reimbursement Scenario
- MARKET DYNAMICS
-
- Drivers
- Restraints/Challenges
- Opportunities
- GLOBAL VETERINARY VACCINES MARKET - ANALYSIS & FORECAST, BY ANIMAL TYPE
-
- Livestock Animals
- Companion Animals
- GLOBAL VETERINARY VACCINES MARKET - ANALYSIS & FORECAST, BY ROUTE OF ADMINISTRATION
-
- Oral
- Parenteral
- GLOBAL VETERINARY VACCINES MARKET - ANALYSIS & FORECAST, BY VACCINE TYPE
-
- Live Attenuated Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- Inactivated Vaccines
- Other Vaccines Type (Subunit Vaccine, Conjugate Vaccine, and DNA Vaccine)
Future Outlook:
The report provides a forward-looking perspective on the Veterinary Vaccines market, offering insights into potential growth opportunities, emerging trends, and factors that could shape the market in the coming years. With a growing emphasis on animal welfare and the role of preventive healthcare in veterinary medicine, the global market is poised for sustained growth.
In conclusion, the report serves as a valuable resource for industry stakeholders, providing a comprehensive analysis of market trends, challenges, and opportunities. As the importance of animal health becomes increasingly recognized, the Veterinary Vaccines market is expected to play a pivotal role in ensuring the well-being of both livestock and companion animals.
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- 'Business Profile' of Key Players
Buy this Premium Research Report: https://www.growthplusreports.com/checkout-7655
Browse other reports:
According to the deep-dive market assessment study by Growth Plus Reports, the global continuous renal replacement therapy market was valued at US$ 1.19 billion in 2021 and is expected to register a revenue CAGR of 7.4% to reach US$ 2.26 billion by 2030.
According to the deep-dive market assessment study by Growth Plus Reports, the global infection control market was valued at US$ 215.34 billion in 2021 and is expected to register a revenue CAGR of 6.5% to reach US$ 379.55 billion by 2030.
According to the deep-dive market assessment study by Growth Plus Reports, the global invasive fungal infection therapeutics market was valued at US$ 7.21 billion in 2021 and is expected to register a revenue CAGR of 4.10% to US$ 10.36 billion by 2030.
According to the deep-dive market assessment study by Growth Plus Reports, the global NGS-based RNA sequencing market was valued at US$ 2.81 billion in 2021 and is expected to register a revenue CAGR of 19.85% to reach US$ 14.36 billion by 2030.
According to the deep-dive market assessment study by Growth Plus Reports, the global respiratory inhalers market was valued at US$ 25.23 billion in 2021 and is expected to register a revenue CAGR of 6.1% to reach US$ 42.99 billion by 2030.
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as Most Innovative Healthcare Market Research Company in 2020.
